Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational TrialJohn M.S. Bartlett, Daniel Rea, Lucinda Billingham et al.|Journal of Clinical Oncology|2011Cited by 199
Heterogeneous<i>HER2</i>Gene AmplificationAlastair I. Bartlett, John M.S. Bartlett, Jane Starcyznski et al.|American Journal of Clinical Pathology|2011Cited by 106